Semaglutide cost with insurance in 2026: Wegovy, Ozempic, and what your plan will really pay

Find your situation first. Each line points to the route that usually works best.

• Employer plan that covers Wegovy: get the prior authorization approved, then add the Wegovy savings card. Prior authorization, or PA, is your plan's approval before it pays.
• Type 2 diabetes: Ozempic is the covered name. Most plans pay for it after a PA, and the Ozempic savings card can cut your share to about $25.
• Ozempic prescribed for weight only: expect a denial. Ask your prescriber about Wegovy, the same medicine approved for weight.
• Medicare: Ozempic goes through your Part D plan for diabetes. For weight, the GLP-1 Bridge offers Wegovy for $50 a month if you meet its rules.
• Medicaid: Ozempic is covered for diabetes in every state. Wegovy for weight depends on your state, and fewer states pay for it in 2026.
• Denied with no appeal left: Novo's self-pay Wegovy pill starts at about $150 a month, the same price whether you are insured or not.

Every way to pay for semaglutide with insurance, option by option

The table mixes four kinds of help. Novo's cards lower your copay, Medicare runs its own programs, online clinics handle the paperwork, and cash routes catch you after a no. Here is each one in turn.

Wegovy savings card: best when your plan covers Wegovy

This is Novo Nordisk's copay coupon for commercial insurance, meaning an employer or marketplace plan. Your plan must already cover Wegovy, pen or pill.

You can pay as little as $25 a month. The card pays at most $100 a month, so if your plan charges more than $125, you pay the difference.

Ozempic savings card: best if you have type 2 diabetes

The Ozempic card works the same way, with the same $25 floor and $100 monthly cap. It covers the Ozempic pen and the Ozempic pill.

Ozempic is approved only for type 2 diabetes uses, so plans rarely cover it for weight alone. Without coverage, the card cannot help. Our Ozempic savings page has the fine print.

Medicare GLP-1 Bridge: best on Medicare

Since July 1, 2026, Medicare members who meet its rules can get Wegovy for $50 a month, pen or pill. Ozempic is not part of it. The rules are in the Medicare section below.

Medicare Part D: Ozempic for type 2 diabetes

Part D is Medicare's drug coverage. If you have type 2 diabetes, your Part D plan usually pays for Ozempic after a prior authorization.

In 2026, your yearly out-of-pocket cost for all covered drugs stops at $2,100. The savings card never works here, so compare plans on Medicare's plan finder before you enroll.

Ro: best for full-service insurance help

Ro's insurance team checks your coverage, files the prior authorization and handles appeals. Ro says a prior authorization usually takes about one to two weeks.

Ro bills insurance for only three drugs: the Wegovy pen, the Zepbound pen and Ozempic. The Wegovy pill is not on that list, so at Ro you pay its cash price.

The Ro Body membership is about $150 a month after a first month of about $40. Prepaying a year brings it to about $75 a month, and insurance never pays the membership.

Medicaid members cannot use Ro, and Medicare members get cash-pay options only. Its weight program is not offered in Hawaii, Louisiana, Mississippi or Virginia. Ro holds 3.9 stars on Trustpilot from about 6,800 reviews. Details are in our Ro insurance review.

WeightWatchers Med+: best if you also want coaching

Med+ is the WeightWatchers clinic program. Its care team handles prior authorizations and refills with your plan. Its menu lists Wegovy, pen or pill, but not Ozempic.

The first month costs $25. After that, the membership is about $75 a month on a 12-month plan, or about $85 on a 6-month plan. The medicine is billed separately, or as your copay if your plan covers it.

WeightWatchers holds 4.0 stars on Trustpilot from about 4,900 reviews, a score that covers the whole brand. Some members report trouble leaving a long plan early. More in our WeightWatchers insurance review.

Mochi Health: obesity-medicine doctors who file the PA

Mochi's doctors are board-certified in obesity medicine. Its team submits prior authorizations for branded Wegovy and Ozempic. Once approved, you fill at a regular pharmacy for your plan's copay.

The membership is about $80 a month, and new members get the first month free, though not in every state. A prepaid year brings it to about $50 a month, and HSA and FSA money is accepted.

Mochi also sells compounded semaglutide, which is always cash-pay. It holds 4.5 stars on Trustpilot from about 18,800 reviews. See our Mochi Health insurance review.

Hers works differently. It never bills insurance for weight-loss care, as our Hers insurance review explains.

NovoCare self-pay: best if your plan says no

NovoCare Pharmacy is Novo Nordisk's own pharmacy. It sells Wegovy and Ozempic at one self-pay price, whether you have insurance or not.

The pills run from about $150 to about $300 a month, depending on the dose. The pens run about $350 a month, and more at the highest doses. The full price ladder is in the cash section below.

Arbor: the compounded option, never covered

Arbor sells compounded semaglutide, made by partner pharmacies, at one price for every dose. It is about $150 a month on a monthly plan, or about $100 a month if you pay a year upfront.

It is not Wegovy or Ozempic, it is not FDA-approved, and no insurance plan pays for it. Once a prescription is written, Arbor refunds nothing, including prepaid months not yet shipped. It holds 4.5 stars on Trustpilot, but from only about 50 reviews.

Is semaglutide covered by insurance? It depends on the name on your prescription

Plans pay for a drug based on why it is prescribed. Wegovy and Ozempic hold the same medicine, but the FDA approved them for different uses.

• Wegovy pen, weekly shot: approved for weight management and to lower heart attack and stroke risk in adults with heart disease and excess weight. Since August 2025, it also treats MASH, a fatty liver disease with scarring.
• Wegovy pill, daily: approved in December 2025 for weight management and the same heart-risk use. It is not approved for MASH.
• Ozempic pen, weekly shot: approved to control blood sugar in type 2 diabetes and to lower heart risk in people with type 2 diabetes and heart disease. Since January 2025, it is also approved to protect the kidneys in type 2 diabetes with kidney disease.
• Ozempic pill, daily: this is the former Rybelsus, sold as Ozempic in the US since May 4, 2026. It is approved for type 2 diabetes.
• Compounded semaglutide: not FDA-approved, so no plan pays for it.

The diagnosis code on the claim carries that reason to your plan. Type 2 diabetes codes start with E11, and obesity codes start with E66. An Ozempic claim with only an obesity code is usually denied.

One name is easy to mix up. Foundayo is a different pill, orforglipron from Lilly, and it is not semaglutide, even though Medicare's Bridge covers it too. Our Ozempic vs Rybelsus page explains the pill's new name.

How much is semaglutide with insurance each month?

Covered does not mean one fixed price. Three parts of your plan decide what you pay at the counter.

• Copay: a flat amount for each fill. This is the simplest case, and the savings card works best here.
• Coinsurance: a percentage of the drug's price. On a drug that lists above $1,000 a month, even a small percentage reaches the hundreds.
• Deductible: what you pay yourself each year before the plan starts sharing costs. Until you meet it, you may owe the plan's full price.

Coinsurance and deductibles follow the list price, not Novo's self-pay price. The list price is the price Novo sets for wholesalers. It is about $1,350 for a month of Wegovy and about $1,000 for Ozempic.

That gap can flip the math. If your plan charges 30% of Wegovy's list price, your share comes to about $405 a month. Even after the card's $100, that can cost more than paying cash for the pill.

Relief is coming for these plans. Novo plans to cut the list price of Wegovy and Ozempic to about $675 a month on January 1, 2027. Its self-pay prices will not change.

Why January costs more

A high-deductible health plan, or HDHP, starts its deductible over every January. Your first fills of the year can cost hundreds of dollars even when semaglutide is covered.

The savings card still helps, but only up to its monthly cap. Some plans also leave the card's help out of your deductible. This rule is called a copay accumulator, and it stretches out the expensive months.

Ask your plan how it treats manufacturer coupons before January. Our semaglutide cost breakdown shows the full price picture.

How to get semaglutide covered: what prior authorization asks

Most plans want proof before they pay. Your prescriber sends it, and the proof depends on which name you ask for.

• Wegovy, your BMI: a dated BMI of 30 or more, or 27 or more with a weight-related condition. Most plans follow the label here.
• Wegovy, your conditions: high blood pressure, prediabetes, high cholesterol, sleep apnea or heart disease, each diagnosed in your chart.
• Wegovy, lifestyle records: notes from a diet, exercise or behavior program. Some plans set a minimum length.
• Wegovy, renewal: approvals last a set time, and renewal usually asks for proof of weight loss.
• Ozempic, the diagnosis: type 2 diabetes backed by lab work, usually an A1c. The A1c is a blood test that reflects your average blood sugar over about three months.
• Ozempic, metformin first: some plans want you to try metformin, a cheaper first-line diabetes pill, before Ozempic.

Dose steps for each form are explained in our semaglutide dosage guide.

Does menopause weight gain count?

Not on its own. Menopause is not an approved use for Wegovy or Ozempic, and insurers do not use it as a criterion. What counts is your BMI and the conditions in your chart.

Midlife often brings those conditions. Blood pressure, blood sugar and cholesterol tend to shift in the 40s and 50s, and sleep apnea grows more common with age.

If a routine test shows prediabetes or high blood pressure, make sure it is diagnosed before the request goes out. If it shows type 2 diabetes, Ozempic becomes a covered option.

Hormone therapy treats menopause symptoms but is not a weight-loss drug. Our guide to perimenopause weight-loss medication explains how these drugs fit this stage of life.

The $25 savings cards: which one, and does it work on my dose or the pill?

Use the card that matches the name on your prescription. Both come from Novo Nordisk and follow the same rules.

• Activate it: sign up on NovoCare's site, or text SAVE to 83757 for the Wegovy card. Then give the card numbers to your pharmacy with your insurance card.
• The cap: you pay as little as $25, but the card pays at most $100 for a month's supply. If your plan charges $300, you still pay $200.
• Your dose: the $25 floor does not change with the dose. Both cards cover the pen and the pill.
• A month's supply: one box of Wegovy pens, one Ozempic pen, or one bottle of 30 tablets.
• Who is left out: Medicare, Medicaid, TRICARE, VA and other government plans. Novo counts anyone with both a work plan and a government plan as government-insured.
• Who counts as commercial: employer plans, marketplace plans, federal employee plans and state employee plans.

Activation steps and the fine print are on our Wegovy savings page. Our semaglutide savings guide compares every program.

Does Medicare cover semaglutide in 2026?

Part D cannot pay for drugs used only for weight loss. Semaglutide gets in three other ways.

• Ozempic for type 2 diabetes: Part D plans cover it, usually after a prior authorization.
• Wegovy for heart risk or MASH: Part D plans can cover it for these approved uses.
• The GLP-1 Bridge: a temporary program for weight, at $50 a month for Wegovy.

When Part D covers your drug, your 2026 out-of-pocket costs for all covered drugs stop at $2,100. No plan may charge a deductible above $615 this year.

The GLP-1 Bridge: Wegovy for $50 a month

The Bridge runs from July 1, 2026 to December 31, 2027. It covers the Wegovy pen and pill, along with Foundayo and the Zepbound KwikPen. Ozempic is not covered.

• Price: $50 for a one-month supply, whatever your income. It does not count toward your Part D deductible or yearly cap.
• Who qualifies: a BMI of 35 or more, or a BMI of 27 or 30 and up with certain heart, blood pressure, kidney or prediabetes conditions.
• Who is left out: people with type 2 diabetes, moderate to severe sleep apnea or fatty liver disease. Anyone whose Part D plan already pays for a GLP-1 also stays with the plan.
• How to start: your prescriber sends the prescription, the pharmacy confirms your Medicare number, then your prescriber files an approval form. Refills on the same drug need no new approval, even when the dose changes.

The exact BMI tiers are listed on our Wegovy insurance page.

A lower Medicare price starts in 2027

Medicare negotiated one price for semaglutide, covering Ozempic, Wegovy and the former Rybelsus. From January 1, 2027, Medicare will pay $274 for a 30-day supply.

That is what Medicare pays the maker, not your copay. It can still lower your share in months when your plan charges a percentage of the price.

Turning 65 on semaglutide

The savings card stops once you enroll in a Medicare drug plan, even if you keep a work plan. Plan the switch a few months ahead.

If you take Ozempic for diabetes, compare Part D plans on how they list Ozempic, not just on premium. If you take Wegovy for weight and meet the Bridge rules, ask your prescriber to set up a Bridge prescription for your Medicare start date.

Does Medicaid cover semaglutide?

Ozempic, yes, for type 2 diabetes in every state. States must cover diabetes drugs, often after a prior authorization or a metformin trial.

Wegovy for weight depends on your state, because covering weight-loss drugs is optional for Medicaid. KFF counted 13 state programs covering GLP-1s for obesity in January 2026.

California, New Hampshire, Pennsylvania and South Carolina dropped that coverage in January 2026. Massachusetts followed on July 3, 2026, so the count has fallen again.

Other uses can still open the door. Massachusetts kept paying for Wegovy to lower heart risk or treat MASH, with a prior authorization. Ask your Medicaid plan about Wegovy by name and by use.

Medicaid copays stay small, but the savings cards do not apply. Our Ozempic insurance page covers Medicaid rules for diabetes in more detail.

Which insurance plans cover Wegovy and Ozempic in 2026?

No insurer covers semaglutide the same way for everyone. The real decision usually sits with your employer and your PBM, the pharmacy benefit manager that runs your drug list.

• CVS Caremark: Wegovy has been its preferred weight-loss GLP-1 since July 2025. Since October 1, 2026, Zepbound sits beside it as a co-preferred option on its standard lists.
• Express Scripts and Optum Rx: diabetes coverage is standard, while weight-loss coverage is usually an add-on your employer chooses.
• Aetna, Cigna, UnitedHealthcare and Blue plans: each follows its PBM's list plus your employer's choices. Two people with the same insurer can get different answers.
• Marketplace plans: weight-loss drugs are not a required benefit, and few marketplace plans cover Wegovy for weight.
• Federal employees: every FEHB plan must cover at least one GLP-1 for weight loss. For 2027, plans must also require an intensive lifestyle program before and during treatment.
• TRICARE: Prime and Select cover weight-loss drugs with a PA. TRICARE For Life stopped covering them on August 31, 2025, but Ozempic stays covered for diabetes.
• VA: semaglutide can be covered under set criteria, often alongside a weight program. Ask your VA prescriber.

Employers are the moving part. Some dropped weight-loss coverage for 2026, so read this year's plan documents, not last year's.

Prescribed Ozempic for weight, or your plan excludes weight-loss drugs?

This is the most common semaglutide denial. A weight-only Ozempic prescription is off-label, meaning outside its approved uses, and plans almost always refuse it.

• Switch the name: ask your prescriber for Wegovy instead. It is the same medicine, approved for weight, and a plan that covers weight-loss drugs can approve it.
• Heart route: if you have had a heart attack, stroke or blocked leg arteries and carry extra weight, Wegovy can be requested to lower heart risk. Some plans review this use apart from weight loss.
• Liver route: a MASH diagnosis with moderate to advanced scarring is another approved use for the Wegovy pen.
• Formulary exception: you can ask the plan to cover a drug it does not list. Marketplace and small-group plans must answer within 72 hours, or 24 hours when it is urgent.
• HR: some employers buy weight-loss coverage as an add-on, often called a rider. Ask whether it exists and whether it is up for review.
• Open enrollment: each fall, compare plans on Wegovy coverage, not just premiums. A spouse's plan is worth checking too.

Our Ozempic vs Wegovy comparison explains why one medicine carries two names and two sets of rules.

Semaglutide denied by insurance? How to appeal

Start with the reason on the letter. Missing proof can be fixed, while a weight-only Ozempic denial is better solved by switching to Wegovy.

• Ask for a peer-to-peer: your prescriber talks directly with the plan's reviewing doctor. It can settle a paperwork denial quickly.
• File an internal appeal: you have 180 days from the denial notice. For a drug you have not started, the plan must decide within 30 days.
• Send a strong letter: list your BMI history, each diagnosed condition and the programs you tried. Quote the plan's own criteria and show how you meet each one.
• Request an external review: if the plan says no again, you have 4 months to ask for an independent review. A standard decision comes within 45 days.

Your plan type decides who oversees the process. Self-funded employer plans, where the employer pays claims itself, fall under ERISA, the federal benefits law enforced by the Department of Labor.

Plans bought from an insurer, including marketplace plans, also answer to your state insurance department. Medicare and Medicaid have their own steps, listed on your denial notice.

No one publishes a reliable success rate for semaglutide appeals. Be wary of anyone who quotes one.

If your plan says no: the cheapest ways to get semaglutide

A denial does not push you to the list price. Novo's self-pay prices through NovoCare Pharmacy are the same whether you are insured or not.

• Pill, starting dose of 1.5 mg: about $150 a month, Wegovy or Ozempic.
• Pill, 4 mg: about $200 a month.
• Pill, higher doses: about $300 a month for Wegovy 9 mg and 25 mg, or Ozempic 9 mg.
• Pen, first two fills: about $200 each at the starting doses, for new patients, through December 31, 2026.
• Pen, regular price: about $350 a month for Wegovy up to 2.4 mg or Ozempic up to 1 mg.
• Highest pen doses: about $400 for Wegovy HD 7.2 mg, and about $500 for Ozempic 2 mg.

Our semaglutide without insurance page ranks every cash route. Wegovy without insurance and Ozempic without insurance go deeper on each name.

Novo's patient assistance program gives Ozempic free to uninsured people with low incomes. It does not list Wegovy, and people with private insurance or Medicaid cannot apply.

Compounded semaglutide: cheaper, never covered

Compounded semaglutide is made by a pharmacy from the same active ingredient. It is not Wegovy or Ozempic, it is not FDA-approved, and no insurance plan pays for it.

The FDA declared the semaglutide shortage over in February 2025, which narrowed who can legally compound it. The FDA has also proposed keeping semaglutide off the list that large outsourcing pharmacies, called 503B facilities, may compound from.

At Arbor, it costs about $150 a month, or about $100 a month on a prepaid year, at every dose. Our compounded semaglutide guide explains its legal status.

What a year of semaglutide costs with insurance vs without

Monthly prices hide the real total. A box of pens lasts four weeks, so a year holds 13 pen fills, while a bottle of pills lasts a month. Here is a first year in common situations, at today's prices, following the label's dose steps.

• Covered, copay plan, savings card: about $25 a fill, so about $300 to $325 a year.
• Medicare GLP-1 Bridge, Wegovy: $50 a fill, so about $600 a year on the pill and $650 on the pen.
• Medicare Part D, Ozempic for diabetes: at most $2,100 in 2026 for all your covered drugs.
• Covered, with Mochi's prepaid membership: about $590 for the membership plus about $325 in card copays, so about $910.
• Covered, with WeightWatchers Med+ on a 12-month plan: about $840 for the membership plus about $325 in card copays, so about $1,160.
• Covered, with Ro's prepaid membership: about $890 for the membership plus about $325 in card copays, so about $1,210.
• Covered, high-deductible plan: say your deductible is $3,000 and the plan's price is Wegovy's list price. The first two fills cost about $1,250 each after the card, the third about $200, then about $25. The year comes to about $2,950, more with a copay accumulator.
• Arbor compounded, year paid upfront: about $1,190, or at least about $1,790 on the monthly plan.
• Denied, Novo self-pay pill: one month at about $150, one at about $200, then about $300 a month. The first year comes to about $3,340.
• Denied, Novo self-pay pen at regular doses: two starter fills at about $200, then about $350 a fill. The first year comes to about $4,240.

A covered year with the card costs about $325, and a self-pay pen year about $4,240. That gap is why an afternoon of paperwork pays off.